In GSE4170, the expression of ASF1A, but not ASF1B, was much higher in CML-BC (n = 28) than in CML-CP (n = 42) patients (Fig. 1a and Supplementary Fig. S1a). This evidence concerns the gene ASF1A and chronic myelogenous leukemia, BCR-ABL1 positive.